Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/319324

Lähdeviite

Roumans , K H M , Lindeboom , L , Veeraiah , P , Remie , C M E , Phielix , E , Havekes , B , Bruls , Y M H , Brouwers , M C G J , Stahlman , M , Alssema , M , Peters , H P F , de Mutsert , R , Staels , B , Taskinen , M-R , Boren , J , Schrauwen , P & Schrauwen-Hinderling , V B 2020 , ' Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance ' , Nature Communications , vol. 11 , no. 1 , 1891 . https://doi.org/10.1038/s41467-020-15684-0

Julkaisun nimi: Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
Tekijä: Roumans, Kay H. M.; Lindeboom, Lucas; Veeraiah, Pandichelvam; Remie, Carlijn M. E.; Phielix, Esther; Havekes, Bas; Bruls, Yvonne M. H.; Brouwers, Martijn C. G. J.; Stahlman, Marcus; Alssema, Marjan; Peters, Harry P. F.; de Mutsert, Renee; Staels, Bart; Taskinen, Marja-Riitta; Boren, Jan; Schrauwen, Patrick; Schrauwen-Hinderling, Vera B.
Muu tekijä: University of Helsinki, HUS Heart and Lung Center
Päiväys: 2020-04-20
Kieli: eng
Sivumäärä: 11
Kuuluu julkaisusarjaan: Nature Communications
ISSN: 2041-1723
URI: http://hdl.handle.net/10138/319324
Tiivistelmä: Hepatic steatosis is associated with poor cardiometabolic health, with de novo lipogenesis (DNL) contributing to hepatic steatosis and subsequent insulin resistance. Hepatic saturated fatty acids (SFA) may be a marker of DNL and are suggested to be most detrimental in contributing to insulin resistance. Here, we show in a cross-sectional study design (ClinicalTrials.gov ID: NCT03211299) that we are able to distinguish the fractions of hepatic SFA, mono- and polyunsaturated fatty acids in healthy and metabolically compromised volunteers using proton magnetic resonance spectroscopy (H-1-MRS). DNL is positively associated with SFA fraction and is elevated in patients with non-alcoholic fatty liver and type 2 diabetes. Intriguingly, SFA fraction shows a strong, negative correlation with hepatic insulin sensitivity. Our results show that the hepatic lipid composition, as determined by our H-1-MRS methodology, is a measure of DNL and suggest that specifically the SFA fraction may hamper hepatic insulin sensitivity. Hepatic steatosis is associated with poor cardiometabolic health, with de novo lipogenesis (DNL) contributing to hepatic steatosis and subsequent insulin resistance. Here, the authors use H-1-MRS methodology to show hepatic SFA fraction is a measure of DNL and specifically may hamper hepatic insulin sensitivity.
Avainsanat: LIVER-DISEASE
CARDIOVASCULAR-DISEASE
RISK
SPECTROSCOPY
STEATOSIS
BRAIN
MICE
3121 General medicine, internal medicine and other clinical medicine
Tekijänoikeustiedot:


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
s41467_020_15684_0.pdf 1.264MB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot